Searches for new markers in bile duct and gallbladder cancers
Looks for new biomarkers in adults with bile duct or gallbladder cancer.
Plain-language title generated from the registry record
Registry title: Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer
Key facts
- Where
- Herlev, DenmarkSee the site
Where in Denmark
- Herlev & Gentofte HospitalHerlev, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Herlev and Gentofte Hospital
- Trial code
- NCT05184400
- Record updated
- 11 January 2022
- Original description
No validated biomarkers exist that can identify patients with biliary tract cancer at an early stage or predict treatment outcomes. The objective of the present study is to find diagnostic, prognostic and predictive biomarkers.Read full original descriptionShow less
Identification of New Biomarkers for Patients With Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) - do They Provide New Information Regarding Diagnosis, Treatment Efficacy, Side Effects, or Prognosis?
No validated biomarkers exist that can identify patients with biliary tract cancer at an early stage or predict treatment outcomes. The objective of the present study is to find diagnostic, prognostic and predictive biomarkers.
Inclusion: Histological or cytological diagnosis of BTC; Patients referred for treatment of BTC; Signed informed consent.
Exclusion: None.